Innovative Gene Therapy Shows Promise in Reversing Diabetic Heart Disease in Mice and Human Cardiac Tissues
A groundbreaking gene therapy approach targeting glycophagy has demonstrated success in reversing diabetic heart failure in mice and human cardiac tissues, offering new hope for targeted treatment of diabetic cardiomyopathy.
Recent research has demonstrated that a targeted gene therapy approach could potentially reverse diabetic heart failure, as shown in studies involving mice and engineered human heart tissues. Scientists focused on addressing the metabolic dysfunction in diabetic hearts, where the organ's ability to relax properly between beats diminishes, leading to a condition known as diastolic dysfunction.
The team, comprising researchers from New Zealand, Australia, and other countries, uncovered that diabetic hearts lack sufficient levels of a crucial protein necessary for glycogen breakdown—a process vital for energy production. This protein is part of a cellular pathway called glycophagy, which is disrupted in diabetes, resulting in glycogen accumulation and impaired heart function.
Using a modified virus as a vector, the researchers successfully delivered genes to increase levels of GABARAPL1, a key protein involved in glycophagy. This intervention restored the breakdown of glycogen, reduced its buildup, and improved heart relaxation without altering blood sugar levels or overall body weight in diabetic mice. The treatment notably improved cardiac function and presented a novel approach to addressing the underlying metabolic issues in diabetic cardiomyopathy.
In addition to animal models, the therapy was tested on miniature human hearts derived from stem cells. The treatment enhanced their ability to relax during each heartbeat, a critical indicator of healthy heart function. These findings suggest the potential for future clinical applications that directly target the cardiac issues associated with diabetes, rather than merely managing symptoms.
Moreover, preliminary data indicates that sex differences might influence treatment efficacy, with female hearts showing a stronger response, possibly due to more robust glycophagy activity.
Overall, this research offers promising evidence that gene therapy targeting energy recycling pathways could revolutionize treatment strategies for diabetic heart disease, emphasizing the importance of metabolic health in cardiovascular therapy.
Source: https://medicalxpress.com/news/2025-10-gene-therapy-diabetic-heart-disease.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Scanner Enables Early Detection of Bedsores, Enhancing Patient Care and Reducing Healthcare Costs
A revolutionary handheld scanner now detects bedsores early, preventing complications, saving lives, and reducing healthcare costs by providing a more equitable and accurate assessment for diverse patient populations.
Stalking and Its Link to Increased Heart Disease and Stroke Risk in Women
New research reveals that women who have experienced stalking or obtained restraining orders face significantly higher risks of heart attacks and strokes over time, emphasizing the urgent need for healthcare awareness and intervention.
Pharmacists Prepare for Potential Impact of Targeted Trump Pharmaceutical Tariffs
Pharmacists are stockpiling essential medicines amid fears that tariffs proposed by President Trump could lead to drug shortages, higher prices, and pharmacy closures. Experts warn of potential disruptions in the pharmaceutical supply chain and increased costs for consumers.
Enhancing Rural and Indigenous Healthcare through Virtual Care Networks
A groundbreaking virtual care network in British Columbia improves healthcare access for rural and Indigenous communities through real-time virtual support, fostering equity and cultural safety.